|
SOCIETY FOR INHERITED METABOLIC DISORDERS 41st Annual Meeting: April 6 - 9, 2019 April 6: Washington State Convention Center, Seattle, Washington April 7 - 9: Hyatt Regency, Bellevue, Washington |
CME/CEU AND CONTINUING
EDUCATIONAL CREDITS
CME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential
Areas and policies of the Accreditation Council for Continuing Medical Education
through the Joint Providership of the The University of Massachusetts Medical
School and SIMD. The University of
Massachusetts Medical School is accredited by the Accreditation Council for
Continuing Medical Education to provide continuing medical education for
physicians.
Designation Statement
The University of Massachusetts Medical School designates this live activity for
a maximum of 18.5 AMA PRA Category 1
Credit(s)™. Physicians should
claim only credit commensurate with the extent of their participation in the
activity.
Nursing: This offering meets the requirements for a maximum of 22.2 contact hours,
as specified by the Massachusetts Board
of Registration in Nursing (244-CMR 5.04). Each nurse should claim only
those hours of credit that he/she actually spent in the educational activity.
Learning objectives:
1) Recognize how to diagnose and appropriately treat these patients with lysosomal storage and peroxisomal disease in the newborn period.
2) Recognize the signs and symptoms of a metabolic disease with features of multiple malformations/dysmorphology.
3) Recognize the signs and symptoms of the newly discovered metabolic diseases and the important diagnostic test and modes of treatment.
Target Audience:
The target audience will consist of M.D's, D.O's, Physician Assistants, R.N.'s and Nurse
Practitioners.